Answers are grounded in this paper and cite their sources.
Screening FDA-approved oncology drugs identifies romidepsin's potential for osteosarcoma treatment, highlighting its lack of effect on canine sarcospheres.
Sarcospheres derived from cells of a canine patient do not grow over time and romidepsin does not affect diameter
No takes yet. Share an insight, caveat, or question.
Seiden et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: